COVID-19 Impacts and Recovery | Global Hepatitis C Drugs Market Research During 2021-2025 | Technavio

The hepatitis C drugs market is poised to grow by USD 252.89 million during 2021-2025, progressing at a CAGR of almost 1% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005731/en/

Technavio has announced its latest market research report titled Global Hepatitis C Drugs Market 2021-2025 (Graphic: Business Wire).

Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Get FREE Sample Report in Minutes!

The report on the hepatitis C drugs market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by increasing demand for direct-acting antivirals.

The hepatitis C drugs market analysis includes the product and geography landscape. This study identifies the rising number of patient support initiatives as one of the prime reasons driving the hepatitis C drug market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The hepatitis C drugs market covers the following areas:

Hepatitis C Drugs Market Sizing

Hepatitis C Drugs Market Forecast

Hepatitis C Drugs Market Analysis

Companies Mentioned

• AbbVie Inc.
• Astellas Pharma Inc.
• Bristol-Myers Squibb Co.
• Cipla Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Vertex Pharmaceuticals Inc.

Related Reports on Health Care Include:

Global Parkinson's Disease (PD) Drugs Market - The Parkinson's disease (PD) drugs market is segmented by drug class (DA and levodopa-carbidopa, MAO inhibitors, AChE inhibitors, glutamate inhibitors, and others), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report

Global Orphan Drugs Market- The orphan drugs market is segmented by product (biologics and non-biologic), geography (North America, Europe, Asia, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

• Market ecosystem
• Market Characteristics
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Product

• Market segments
• Comparison by Product
• Combination therapy - Market size and forecast 2020-2025
• Monotherapy - Market size and forecast 2020-2025
• Market opportunity by Product

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• ROW - Market size and forecast 2020-2025
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Competitive scenario
• Vendor landscape
• Landscape disruption
• Industry risks

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AbbVie Inc.
• Astellas Pharma Inc.
• Bristol-Myers Squibb Co.
• Cipla Inc.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Vertex Pharmaceuticals Inc.

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005731/en/